Increasing Insulin Lispro to 120 Units Daily via Insulin Pump
For a 70-kg type 1 diabetic, a total daily dose of 120 units of insulin lispro (1.7 units/kg/day) via pump is reasonable and falls within established dosing parameters, though it exceeds typical maintenance requirements and warrants careful evaluation of glycemic control, pump settings, and potential insulin resistance.
Dosing Context and Assessment
The proposed dose of 120 units daily (1.7 units/kg/day) is above the typical range for metabolically stable adults with type 1 diabetes. According to current guidelines 1, 2:
- Standard dosing: 0.4-1.0 units/kg/day for most adults
- Typical starting dose: 0.5 units/kg/day (35 units for 70 kg)
- Higher requirements occur during puberty, pregnancy, and medical illness 2
At 1.7 units/kg/day, this patient is using approximately 170% of the upper typical range, suggesting either:
- Suboptimal glycemic control requiring intensification
- Significant insulin resistance
- Pump setting issues (overbasalization, incorrect carbohydrate ratios)
Critical Evaluation Before Increasing
Before increasing to 120 units, assess for overbasalization 3:
- Bedtime-to-morning glucose differential: Elevated suggests excessive basal insulin
- Postprandial-to-preprandial differential: Large gaps indicate inadequate prandial coverage
- Hypoglycemia patterns: Frequent lows (aware or unaware) suggest overinsulinization
- High glucose variability: May indicate incorrect insulin-to-carbohydrate ratios
Typical basal-bolus split: 30-50% basal, 50-70% prandial 2. If basal exceeds 50% of total daily dose, consider this a red flag for overbasalization requiring adjustment rather than simple dose escalation.
Pump-Specific Considerations
Insulin lispro is FDA-approved and effective for pump use 4. Studies demonstrate:
- Comparable or superior glycemic control versus regular insulin in pumps 5, 6
- Mean HbA1c reduction from 7.8% to 7.2% over 12 weeks 4
- Similar hypoglycemia rates to other rapid-acting analogs 4
For doses this high (120 units/day), practical pump management requires:
- More frequent cartridge changes (standard 200-unit cartridge lasts <2 days)
- Consider concentrated insulin formulations if available and appropriate 7
- Verify infusion set integrity to prevent unexplained hyperglycemia
When to Increase vs. Optimize
Increase the dose if:
- A1C remains >7% (or individualized target) despite optimal pump settings
- Persistent hyperglycemia without hypoglycemia
- Documented insulin resistance (obesity, concurrent illness, medications)
- Proper basal-bolus distribution maintained
Optimize settings instead if:
- Basal insulin >50% of total daily dose
- Frequent hypoglycemia alternating with hyperglycemia
- Large postprandial excursions suggesting incorrect carbohydrate ratios
- Dawn phenomenon manageable with pump programming
Titration Strategy
If increasing is appropriate 3:
- Incremental adjustments: Increase by 10-15% (not exceeding 2-4 units per adjustment)
- Target specific problems: Address fasting vs. postprandial hyperglycemia separately
- Reassess every 3-6 months: Avoid therapeutic inertia but prevent overtreatment
- Monitor for hypoglycemia: If occurs without clear cause, reduce dose by 10-20%
Safety Considerations
At 120 units daily, heightened vigilance for:
- Severe hypoglycemia: Risk increases with higher doses 4
- Weight gain: Documented with intensive insulin therapy 4
- Pump occlusions: Higher insulin volumes increase mechanical failure risk 8
- Diabetic ketoacidosis: Pump failure at high doses creates rapid decompensation risk 4
Prescribe glucagon for emergent hypoglycemia at these insulin doses 3.
Alternative Considerations
If glycemic targets remain unmet despite 120 units/day:
- Consider automated insulin delivery (AID) systems for superior glycemic control 2, 9
- Evaluate for adjunctive therapies if appropriate (though primarily for type 2 diabetes)
- Assess adherence, carbohydrate counting accuracy, and diabetes self-management education needs
Common Pitfalls
- Overbasalization: Reflexively increasing total insulin without evaluating basal-bolus distribution
- Ignoring hypoglycemia: Treating high glucose without addressing preceding lows
- Inadequate monitoring: Failing to use continuous glucose monitoring at these doses
- Pump setting errors: Incorrect insulin-to-carbohydrate ratios or correction factors masquerading as insulin resistance